PURPOSE: The purpose of this study was to investigate the changes of tumor hypoxia as a result of neoadjuvant chemotherapy (NAC) by measuring the changes of [(18)F]fluoromisonidazole ([(18)F]FMISO) positron emission tomography (PET) uptake, as well as to look into the ability of [(18)F]FMISO PET to predict the NAC result. PROCEDURES: A total of 13 patients with locally advanced head and neck squamous cell carcinoma underwent [(18)F]FMISO PET scans before and after NAC. For analysis of PET index, maximum standardized uptake value, tumor-to-muscle ratio, and hypoxic volume (HV) were measured. RESULTS: All PET indexes of [(18)F]FMISO significantly decreased after NAC. Although HV in primary tumor and a few indexes before NAC in responder was lower than that in nonresponder, none of the indexes were statistically significant. CONCLUSIONS: Pretreatment [(18)F]FMISO could not predict NAC outcome in this study. However, [(18)F]FMISO uptake significantly decreased after NAC, and [(18)F]FMISO PET seemed to be a useful noninvasive tool for detecting hypoxia reduction after NAC.
PURPOSE: The purpose of this study was to investigate the changes of tumor hypoxia as a result of neoadjuvant chemotherapy (NAC) by measuring the changes of [(18)F]fluoromisonidazole ([(18)F]FMISO) positron emission tomography (PET) uptake, as well as to look into the ability of [(18)F]FMISO PET to predict the NAC result. PROCEDURES: A total of 13 patients with locally advanced head and neck squamous cell carcinoma underwent [(18)F]FMISO PET scans before and after NAC. For analysis of PET index, maximum standardized uptake value, tumor-to-muscle ratio, and hypoxic volume (HV) were measured. RESULTS: All PET indexes of [(18)F]FMISO significantly decreased after NAC. Although HV in primary tumor and a few indexes before NAC in responder was lower than that in nonresponder, none of the indexes were statistically significant. CONCLUSIONS: Pretreatment [(18)F]FMISO could not predict NAC outcome in this study. However, [(18)F]FMISO uptake significantly decreased after NAC, and [(18)F]FMISO PET seemed to be a useful noninvasive tool for detecting hypoxia reduction after NAC.
Authors: P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther Journal: J Natl Cancer Inst Date: 2000-02-02 Impact factor: 13.506
Authors: Seung Jun Oh; Dae Yoon Chi; Christoph Mosdzianowski; Jung Young Kim; Hee Seop Gil; Se Hun Kang; Jin Sook Ryu; Dae Hyuk Moon Journal: Nucl Med Biol Date: 2005-11 Impact factor: 2.408
Authors: A Paccagnella; M G Ghi; L Loreggian; A Buffoli; H Koussis; C A Mione; A Bonetti; F Campostrini; G Gardani; A Ardizzoia; D Dondi; M Guaraldi; R Cavallo; L Tomio; A Gava Journal: Ann Oncol Date: 2009-12-23 Impact factor: 32.976
Authors: Bernd Gagel; Marc Piroth; Michael Pinkawa; Patrick Reinartz; Michael Zimny; Hans J Kaiser; Sven Stanzel; Branka Asadpour; Cengiz Demirel; Kurt Hamacher; Heinz H Coenen; Thomas Scholbach; Payam Maneschi; Ercole DiMartino; Michael J Eble Journal: BMC Cancer Date: 2007-06-28 Impact factor: 4.430
Authors: I N Fleming; R Manavaki; P J Blower; C West; K J Williams; A L Harris; J Domarkas; S Lord; C Baldry; F J Gilbert Journal: Br J Cancer Date: 2014-12-16 Impact factor: 7.640